Clinical Trial Update: ABT-450/Ritonavir/ ABT-267 (ABT-450/r/ABT-267) and ABT-333 Co-Administered With Ribavirin (RBV) in Treatment Naïve and Treatment Experienced Asian Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Compensated Cirrhosis [Phase 3]

View source ↗

Summary

Phase 3 trial update of ABT-450/r/ABT-267 plus ABT-333 with ribavirin in treatment-naïve and experienced Asian adults with genotype 1b chronic hepatitis C and c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• ABT-333 (ABT-333)
• ABT-450/r/ABT-267
• Ribavirin (ribavirin)

Snippet

Sponsor: AbbVie | Conditions: Chronic Hepatitis C Virus (HCV) | Phase 3 | Status: COMPLETED | Results posted: 2018-10-09